Wrongful Death

December 18, 2009

Prempro Litigation and Menopause

American women in the 1990s were told they could help their bodies ward off major illness by taking menopausal hormone drugs. Some medical associations said so. Many gynecologists and physicians said so. Respected medical journals said so, too.

Along the way, television commercials positioned hormone drugs as treatments for more than hot flashes and night sweats — just two of the better-known symptoms of menopause, which is technically defined as commencing one year after a woman’s last menstrual cycle.

One commercial about estrogen loss by the drug maker Wyeth discussed research into connections between menopause and heart disease, Alzheimer’s disease and blindness.

December 16, 2009

Glaxo Said to Have Paid $1 Billion in Paxil Suits

by Dr. Shezad Malik

GlaxoSmithKline Plc has paid almost $1 billion to resolve lawsuits over Paxil since it introduced the antidepressant in 1993, including about $390 million for suicides or attempted suicides said to be linked to the drug, according to court records and people familiar with the cases.

As part of the total, Glaxo, so far has paid $200 million to settle Paxil addiction and birth-defect cases and $400 million to end antitrust, fraud and design claims, according to the people and court records.

December 12, 2009

Daughter Awarded $3 M After Death of Mom Who Had Do-Not-Resuscitate Order

by Dr. Shezad Malik

Janie Vinson was apparently so ill with chronic obstructive pulmonary disease that the 79-year-old woman’s family told the medical staff at Albany, Ga.’s Phoebe Putney Memorial Hospital not to try to cure her, but to simply keep her comfortable until she died.

A Dougherty County jury awarded her daughter $3 million for medical malpractice claims resulting from Vinson’s death in March 2002 after she was given what a plaintiff’s expert said was too much morphine too quickly.

Vinson had been in the hospital for more than a week when she suffered respiratory arrest on March 18, 2002. Vinson had stopped breathing by the time a nurse arrived to her room. The nurse called a “code” and the emergency pulmonary team, led by Dr. Thomas Ungarino, responded, but by the time they arrived, Vinson was breathing again.

December 7, 2009

Fort Worth Texas Yaz Yasmin Birth Control Lawsuit Update

by Dr. Shezad Malik

After 13 hours of intensifying pain, two trips to the emergency room and two CT scans, doctors finally found what was ailing Lottie Green.

In her left lung, the pulmonologist told her, was the largest blood clot they had ever seen and there were others in her right lung as well, she said.

Soon after the 41-year-old Bethesda, Md., resident was released from a hospital last month, Ms. Green joined hundreds of other women in lawsuits against Germany’s Bayer AG, the maker of the popular oral contraceptive Yaz.

December 6, 2009

FDA Review Says MRI Imaging Drugs That Contain Gadolinium Riskier for Kidney Patients

by Dr. Shezad Malik

The U.S. Food & Drug Administration is weighing further regulation of three drugs used to create high-contrast images on MRI scans, based on a new analysis that suggests they carry a higher risk of causing a rare, but potentially fatal disease.

The issue, marks a setback for GE Healthcare (GE), which contends that its product is no riskier than competing imaging drugs. FDA reviewers said GE’s drug, Omniscan, had a disproportionately high number of reports of the disease compared with its peers.

December 5, 2009

Public Citizen Asks FDA to Ban Weight Loss Pill

by Dr. Shezad Malik

A consumer advocacy group is petitioning the government to ban the weight loss pill Meridia because a recent study suggests it increases risk of heart attack, stroke and death.

A letter Thursday from Public Citizen calls on the Food and Drug Administration to pull Abbott Laboratories’ drug from the U.S. market, where it is used by roughly a quarter million people.

Preliminary results from a 10,000-patient study — known as the SCOUT study — showed a slightly higher risk of heart-related problems in patients taking Meridia, also called sibutramine, compared with a dummy pill. Patients in the study were older than 55, overweight with a history of heart disease or diabetes.

December 4, 2009

Guard Commander Said KBR Carcinogen Caused his Cancer

by Dr. Shezad Malik

A funeral is set for a retired Indiana National Guard commander who testified in October that exposure to a lethal carcinogen in Iraq caused his cancer.

Lt. Col. James C. Gentry, 52, Williams, Ind., died of lung cancer. His death is a marker in a pending federal lawsuit; his life inspired a federal bill working its way through Congress.

December 4, 2009

Asbestos Mesothelioma Payout System is Being Questioned

by Dr. Shezad Malik

Once upon a time, asbestos was practically everywhere. Because the material causes devastating forms of cancer and lung disease, huge product-liability litigation sprung up. That led to huge settlements, which led to the establishment of huge trusts, created to assure payment to millions of current and future claimants.

Some $20 billion now resides in these 40 or so trusts, set up by Johns Manville Corp., Owens Corning and other former makers and sellers of asbestos. But who’s overseeing the trusts? Is the money getting spent properly? In short, are the trusts working as designed?

December 2, 2009

Jury Awards $89 M Against Drunken Driver for Wrongful Death Car Crash

by Dr. Shezad Malik

A jury has awarded $89 million in damages to the family of a man killed in a 2008 crash with a drunken driver, and to the man’s fiancée and daughter.

“The eye-popping numbers were the jury’s attempt to send a message the only way they could,” said attorney Mark Bronson, who won the case after a one-day trial in Franklin County Circuit Court.

He said he doubts his clients will ever see a fraction of the money. But he said the jury’s disgust with drunken driving was unmistakable.

November 30, 2009

Federal Safety Regulators Announce New Crib Recall

by Dr. Shezad Malik

The head of the Consumer Product Safety Commission conceded that the agency “hasn’t been acting as quickly as it should” on crib safety problems.

More than 2.1 million drop-side cribs by Stork Craft Manufacturing of Canada are being recalled following reports of four infant suffocations. The CPSC said the recall involves 1.2 million cribs in the United States and almost 1 million in Canada, where Stork Craft is based. Sales of the cribs being recalled go back to 1993 and nearly 150,000 of the cribs carry the Fisher-Price logo.